
Global & United States Laparoscopic Devices Market to 2031
Description
The United States maintains its leading position in the global laparoscopic devices market, supported by its highly advanced healthcare infrastructure, rapid adoption of innovative surgical technologies, and substantial investments in research and development. This leadership is further strengthened by the widespread use of minimally invasive surgical methods, such as laparoscopic and robotic surgeries, which are gradually replacing conventional open surgeries. These minimally invasive techniques offer improved patient outcomes, including reduced postoperative pain, shorter hospital stays, and faster recovery.
A key factor driving this dominance is the growing prevalence of chronic conditions that often require complex surgeries. According to an August 2022 report from the American College of Cardiology, diabetes rates in the US are expected to increase by 39.3% (reaching 55 million people) and obesity rates by 18.3% (totaling 126 million people) between 2025 and 2060, fueling greater demand for laparoscopic and robotic procedures.
The US also leads in technological innovation and design, as evidenced by the rapid growth of robot-assisted surgery systems, expanding at an annual rate of 25%. Over 2,000 hospitals nationwide currently employ robotic surgery platforms. For example, Intuitive Surgical's da Vinci systems performed more than 2.68 million procedures globally in 2024, with a 25% increase in general surgeries in the US driving this growth. Furthermore, in February 2024, the FDA approved Virtual Incision Corporation’s miniaturized robotic-assisted surgical device, the MIRA Surgical System, for colectomy procedures. Additionally, Ethicon (Johnson & Johnson) introduced an AI-powered laparoscopic surgical simulation platform in November 2023. The widespread integration of advanced 4K and 3D imaging systems, alongside continuous enhancements in energy devices and handheld instruments, is expanding laparoscopic capabilities across the country. The strong presence of major international medical device manufacturers, combined with strategic investments in R&D and distribution, reinforces the US’s dominant position. Many new product approvals and launches, such as disposable suction-irrigation systems with built-in smoke filters, anticipated by late 2024 or early 2025, are taking place in this innovative market.
Moreover, the increasing number of ambulatory surgical centers (approximately 9,600 as of 2024) reflects a growing preference for same-day, cost-effective surgical options. Technological breakthroughs, including the FDA’s approval of Levita’s MARS magnetic surgery platform in August 2023, further demonstrate the US’s pioneering role in advancing laparoscopic surgery.
A key factor driving this dominance is the growing prevalence of chronic conditions that often require complex surgeries. According to an August 2022 report from the American College of Cardiology, diabetes rates in the US are expected to increase by 39.3% (reaching 55 million people) and obesity rates by 18.3% (totaling 126 million people) between 2025 and 2060, fueling greater demand for laparoscopic and robotic procedures.
The US also leads in technological innovation and design, as evidenced by the rapid growth of robot-assisted surgery systems, expanding at an annual rate of 25%. Over 2,000 hospitals nationwide currently employ robotic surgery platforms. For example, Intuitive Surgical's da Vinci systems performed more than 2.68 million procedures globally in 2024, with a 25% increase in general surgeries in the US driving this growth. Furthermore, in February 2024, the FDA approved Virtual Incision Corporation’s miniaturized robotic-assisted surgical device, the MIRA Surgical System, for colectomy procedures. Additionally, Ethicon (Johnson & Johnson) introduced an AI-powered laparoscopic surgical simulation platform in November 2023. The widespread integration of advanced 4K and 3D imaging systems, alongside continuous enhancements in energy devices and handheld instruments, is expanding laparoscopic capabilities across the country. The strong presence of major international medical device manufacturers, combined with strategic investments in R&D and distribution, reinforces the US’s dominant position. Many new product approvals and launches, such as disposable suction-irrigation systems with built-in smoke filters, anticipated by late 2024 or early 2025, are taking place in this innovative market.
Moreover, the increasing number of ambulatory surgical centers (approximately 9,600 as of 2024) reflects a growing preference for same-day, cost-effective surgical options. Technological breakthroughs, including the FDA’s approval of Levita’s MARS magnetic surgery platform in August 2023, further demonstrate the US’s pioneering role in advancing laparoscopic surgery.
Table of Contents
120 Pages
- 1. Introduction
- 1.1 Report Guidance
- 1.2 Market Segmentation
- 2. Executive Summary
- 2.1 Key Insights
- 3. Research Methodology
- 3.1 Secondary Research
- 3.2 Primary Research
- 3.2.1 Data Triangulation and Validation:
- 4. United States Laparoscopic Devices Market Landscape
- 4.1 Overview
- 4.2 Ecosystem Analysis
- 4.2.1 List of Vendors in the Value Chain
- 5. Laparoscopic Devices Market Key Market Dynamics
- 5.1 Laparoscopic Devices Market – Key Market Dynamics
- 5.2 Market Drivers
- 5.3 Market Restraints
- 5.4 Market Opportunities
- 5.5 Future Trends
- 5.6 Impact of Drivers and Restraints
- 6. United States Laparoscopic Devices Market – Analysis
- 6.1 United States Laparoscopic Devices Market Revenue (US$ Million), 2021–2031
- 6.2 United States Laparoscopic Devices Market Revenue and Forecast Analysis
- 7. United States Laparoscopic Devices Market Analysis – by Product
- 7.1 United States Laparoscopic Devices Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Product
- 8. United States Laparoscopic Devices Market Analysis – by Application
- 8.1 United States Laparoscopic Devices Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Application
- 9. United States Laparoscopic Devices Market Analysis – by End User
- 9.1 United States Laparoscopic Devices Market – Revenue and Forecast, 2021–2031 (US$ Million) – by End User
- 10. Competitive Landscape
- 10.1 Heat Map Analysis by Key Players
- 10.1 Company Positioning and Concentration
- 11. Industry Landscape
- 11.1 Overview
- 11.2 Market Initiative
- 11.2 Partnerships and Collaborations
- 11.2 Other Developments
- 12. Company Profiles
- 12.1 Medtronic Plc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 Johnson & Johnson
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 Olympus Corp
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 Stryker Corp
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Karl Storz SE & Co KG
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 Boston Scientific Corp
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 B Braun SE
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 Smith & Nephew Plc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
- 12.9 Conmed Corp
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
- 12.10 Intuitive Surgical Inc
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
- 13. Appendix
- 13.1 About Business Market Insights
- 13.2 List of Abbreviations
- TABLE OF TABLES
- Table 1. United States Laparoscopic Devices Market Segmentation
- Table 2. List of Vendors
- Table 3. United States Laparoscopic Devices Market – Revenue, 2021–2024 (US$ Million)
- Table 4. United States Laparoscopic Devices Market – Revenue Forecast, 2025–2031 (US$ Million)
- Table 5. United States Laparoscopic Devices Market – Revenue, 2021–2024 (US$ Million) – by Product
- Table 6. United States Laparoscopic Devices Market – Revenue Forecast, 2025–2031 (US$ Million) – by Product
- Table 7. United States Laparoscopic Devices Market – Revenue, 2021–2024 (US$ Million) – by Application
- Table 8. United States Laparoscopic Devices Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
- Table 9. United States Laparoscopic Devices Market – Revenue, 2021–2024 (US$ Million) – by End User
- Table 10. United States Laparoscopic Devices Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
- Table 11. List of Abbreviations
- TABLE OF FIGURES
- Figure 1. Impact Analysis of Drivers and Restraints
- Figure 2. United States Laparoscopic Devices Market Revenue, (US$ Million), 2021–2031
- Figure 3. Heat Map Analysis by Key Players
- Figure 4. Company Positioning and Concentration
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.